A. Lalli

Multicenter phase II study of fractionated bimonthly oxaliplatin with leucovorin and 5-fluorouracil in patients with metastatic colorectal cancer, pre-treated with chemotherapy.

G. Mantovani, E. Massa, F. Recchia, 2003, Oncology reports.

Rectal cell proliferation and colorectal cancer risk level in patients with nonfamilial adenomatous polyps of the large bowel

G. Brandi, L. Barbara, G. Biasco, 1991, Cancer.

Ifosfamide, cisplatin, and 13‐Cis retinoic acid for patients with advanced or recurrent squamous cell carcinoma of the head and neck

F. Recchia, G. Saggio, S. Rea, 2001, Cancer.

Carboplatin, ifosfamide, and vinorelbine in the treatment of advanced non-small-cell lung cancer: a phase II study.

A. Lococo, F. Recchia, G. Corrao, 1999, American journal of clinical oncology.

Phase II study of interleukin-2 and 13-cis-retinoic acid as maintenance therapy in metastatic colorectal cancer

S. Necozione, E. Alesse, A. Blasio, 2007, Cancer Immunology, Immunotherapy.

Oxaliplatin fractionated over two days with bimonthly leucovorin and 5-fluorouracil in metastatic colorectal cancer.

E. Biondi, G. Mantovani, E. Massa, 2004, Anticancer research.

Activity of standard-dose carboplatin, cyclophosphamide, and etoposide in patients with metastatic breast cancer with previous exposure to anthracyclines.

F. Recchia, A. Nuzzo, P. Torchio, 1997, American journal of clinical oncology.

Chemoprevention of colorectal cancer: role of antioxidant vitamins

G. Brandi, L. Roncucci, L. Barbara, 1992, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

Cell renewal and cancer risk of the stomach: analysis of cell proliferation kinetics in atrophic gastritis.

G. Brandi, L. Barbara, G. Biasco, 1989, Acta gastro-enterologica Belgica.

Multicentre phase II study of bifractionated CPT-11 with bimonthly leucovorin and 5-fluorouracil in patients with metastatic colorectal cancer pretreated with FOLFOX

F. Recchia, A. Nuzzo, G. Saggio, 2004, British Journal of Cancer.

The CAP-CR study: direct medical costs in Italian metastatic colorectal cancer patients on first-line infusional 5-fluorouracil or oral capecitabine.

C. Iacono, C. Negrini, D. Amoroso, 2008, European journal of cancer.

Effects of sucralfate and sulglycotide treatment on active gastritis and Helicobacter pylori colonization of the gastric mucosa in non-ulcer dyspepsia patients.

L. Barbara, A. Torsoli, F. Pallone, 1990, The American journal of gastroenterology.